ADMA FY 2012 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$449,06240.2% margin

Operating Income

-$8M-707.4% margin

Net Income

-$7M-653.0% margin

EPS (Diluted)

$-1.39

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$626,787

Balance Sheet

Total Assets

$16M

Total Liabilities

$6M

Stockholders' Equity

$9M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$449,062	$0	—
Operating Income	-$8M	-$26,464	-29786.5%
Net Income	-$7M	-$26,460	-27493.8%